ORAL GLUCOSE-LOWERING AGENT TREATMENTS IN TYPE 2 DIABETES MELLITUS

SAZİ IMAMOGLU

Turkish Journal of Internal Medicine - 2021;3(1):1-5

Division of Endocrinology and Metabolism, Department of Internal Medicine, Bursa Uludag University Faculty of Medicine, Bursa, Turkey

 

Yazının özeti bulunmamaktadır